[1] |
LI Zhe, ZUO Ke, WANG Jingjing, ZHOU Houan, JIN Ying, CHEN Guang, LI Shijun, CHENG Zhen, WANG Jinquan, LIU Zhengzhao, XIE Honglang, HU Weixin.
Clinical features and prognosis of COVID-19 in patients with chronic kidney disease
[J]. Chinese Journal of Nephrology, Dialysis & Transplantation, 2023, 32(4): 301-307.
|
[2] |
XIE Kenan, CHENG Dongrui, NI Xuefeng, JIANG Jing, LI Xue, CHEN Jinsong.
Characteristics and prognosis of COVID-19 infection in renal transplant recipients
[J]. Chinese Journal of Nephrology, Dialysis & Transplantation, 2023, 32(4): 308-312.
|
[3] |
CHENG Shuiqin, ZHANG Man, ZHOU Tingting, ZHANG Zhihong, YU Le, CHEN Yunmin, CUI Jingjing, ZHOU Jian, YU Yusheng.
Clinical characteristics and risk factors of COVID19 in peritoneal dialysis patients
[J]. Chinese Journal of Nephrology, Dialysis & Transplantation, 2023, 32(4): 313-317.
|
[4] |
WENG Qinjie, HU Xiaofan, WANG Zhaohui, ZHANG Qianying, YANG Zhenhua.
Single-center analysis of the effect of COVID-19 epidemic on complications in maintenance hemodialysis patients
[J]. Chinese Journal of Nephrology, Dialysis & Transplantation, 2023, 32(4): 318-322.
|
[5] |
HUANG Li, LI Chuan, DONG Jianhua, YANG Xi, WU Bian, GE Yongchun.
Infection and mortality of COVID-19 in maintenance hemodialysis patients
[J]. Chinese Journal of Nephrology, Dialysis & Transplantation, 2023, 32(4): 323-328.
|
[6] |
WANG Qing, REN Yuqian, XIE Honglang.
Glomerular disease associated with COVID-19
[J]. Chinese Journal of Nephrology, Dialysis & Transplantation, 2023, 32(4): 353-357.
|
[7] |
KAN Tingting, SONG Xia, ZHU Ling, ZHANG Haitao.
Management of subjects in clinical trials during the COVID-19 pandemic
[J]. Chinese Journal of Nephrology, Dialysis & Transplantation, 2023, 32(4): 369-372.
|
[8] |
GAO Peijuan, HUANG Wenhui, WEI Xiaofang, LI Yingping, HUANG Junyue, LI Xiaoli, ZHAO Hui, ZHANG Jian, DONG Hui, XUE Rong.
Acquired factor V deficiency in a hemodialysis patient
[J]. Chinese Journal of Nephrology, Dialysis & Transplantation, 2023, 32(1): 95-99.
|
[9] |
XU Jing, LYU Jiayi, CUI Fangzheng, ZHENG Qianwen, FANG Haigu, LI Xiangdong, JIE Yanqing, LIU Lingling, DAI Bing, MEI Changlin, CHEN Jing, MAO Zhiguo.
Application of continuous renal replacement therapy in maintenance hemodialysis in COVID-19 epidemic
#br#
[J]. Chinese Journal of Nephrology, Dialysis & Transplantation, 2022, 31(5): 414-419.
|
[10] |
CHEN Peiling,ZHANG Haitao.
2017 American College of Rheumatology guideline for the prevention and treatment of glucocorticoidinduced osteoporosis
[J]. Chinese Journal of Nephrology, Dialysis & Transplantation, 2018, 27(2): 161-167.
|
[11] |
DONG Jianhua,XU Shutian,TU Yiyao,et al.
The renal impairment in patients with idiopathic hypereosinophilic syndrome
[J]. Chinese Journal of Nephrology, Dialysis & Transplantation, 2017, 26(4): 301-306.
|
[12] |
SHENG Aiqin,TU Yuanmao,GUO Jinzhou,et al.
Glucocorticoid induced diabetic mellitus and related risk factors in patients with primary nephrotic syndrome
[J]. Chinese Journal of Nephrology, Dialysis & Transplantation, 2017, 26(3): 223-228.
|
[13] |
JIAO Chenfeng|XU shutian|TU yuanmao|et al.
Avascular bone necrosis in patients with primary nephrotic syndrome
[J]. Chinese Journal of Nephrology, Dialysis & Transplantation, 2015, 24(4): 307-312.
|
[14] |
LIU Lin|LIU Zhihong.
Progress in mechanism of glucocorticoid action
[J]. Chinese Journal of Nephrology, Dialysis & Transplantation, 2014, 23(5): 472-476.
|
[15] |
HUANG Yan-ru,YUAN Wei-jie.
Signal transduction mechanism of Glucocorticoid-induced osteoporosis
[J]. Chinese Journal of Nephrology, Dialysis & Transplantation, 2013, 22(1): 61-64.
|